Mizuho Securities Assumes National Health Investors at Buy, Announces $95 Price Target

Mizuho Securities analyst Omotayo Okusanya assumes National Health Investors (NYSE:NHI) with a Buy rating and a $95 price target.

Benzinga · 12/20/2019 11:30

Mizuho Securities analyst Omotayo Okusanya assumes National Health Investors (NYSE:NHI) with a Buy rating and a $95 price target.